Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Cramer

Showing results (121-130 of 233) with videos related to

Pageof 24
Sort By:
Reproductive Biology and Endocrinology : RB&E|June 26, 2010
Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epitheliumLifang Zhang, Dan Wang, Wei Jiang, et al.
Cancer Causes & Control : CCC|August 30, 2003
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)Francesmary Modugno, Roxana Moslehi, Roberta B Ness, et al.
Journal of Proteome Research|November 14, 2017
Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in CancerShadi Ferdosi, Douglas S Rehder, Paul Maranian, et al.
Journal of the National Cancer Institute|September 16, 2011
Potential role of HE4 in multimodal screening for epithelial ovarian cancerNicole Urban, Jason D Thorpe, Lindsay A Bergan, et al.
Cancers|July 9, 2022
Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian CancerKristin L M Boylan, Ashley Petersen, Timothy K Starr, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2009
Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancerLiangdan Tang, Junzheng Yang, Shu-Kay Ng, et al.
International Journal of Molecular Epidemiology and Genetics|May 3, 2011
A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studiesKathryn L Terry, Allison F Vitonis, Dena Hernandez, et al.
The Journal of Pathology|September 20, 2018
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumorsKevin M Elias, Petros Tsantoulis, Jean-Christophe Tille, et al.
Cancer Causes & Control : CCC|January 5, 2017
Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association ConsortiumAna Babic, Daniel W Cramer, Linda E Kelemen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of ProgestinsMinh Tung Phung, Alice W Lee, Anna H Wu, et al.
Pageof 24

Showing results (121-130 of 233) with videos related to

Sort By:
Pageof 24
Reproductive Biology and Endocrinology : RB&E|June 26, 2010
Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epitheliumLifang Zhang, Dan Wang, Wei Jiang, et al.
Cancer Causes & Control : CCC|August 30, 2003
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)Francesmary Modugno, Roxana Moslehi, Roberta B Ness, et al.
Journal of Proteome Research|November 14, 2017
Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in CancerShadi Ferdosi, Douglas S Rehder, Paul Maranian, et al.
Journal of the National Cancer Institute|September 16, 2011
Potential role of HE4 in multimodal screening for epithelial ovarian cancerNicole Urban, Jason D Thorpe, Lindsay A Bergan, et al.
Cancers|July 9, 2022
Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian CancerKristin L M Boylan, Ashley Petersen, Timothy K Starr, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2009
Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancerLiangdan Tang, Junzheng Yang, Shu-Kay Ng, et al.
International Journal of Molecular Epidemiology and Genetics|May 3, 2011
A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studiesKathryn L Terry, Allison F Vitonis, Dena Hernandez, et al.
The Journal of Pathology|September 20, 2018
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumorsKevin M Elias, Petros Tsantoulis, Jean-Christophe Tille, et al.
Cancer Causes & Control : CCC|January 5, 2017
Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association ConsortiumAna Babic, Daniel W Cramer, Linda E Kelemen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of ProgestinsMinh Tung Phung, Alice W Lee, Anna H Wu, et al.
Pageof 24